Skip to main content

Day: February 7, 2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 08, 2025 (GLOBE NEWSWIRE) — The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.AttachmentsNotification of managers’ transaction – Anthony RosenbergNotification of managers’ transaction – Pall JohanessonNotification of managers’ transaction – Riad SherifNotification of managers’ transaction – Sylvia Cheung

Continue reading

Euro Sun Closes Third Tranche of Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) — Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that it has closed a third tranche (the “Third Tranche”) of its previously announced non-brokered private placement financing of units of the Company (the “Offering”). Pursuant to the closing of the Third Tranche, the Company issued 5,700,900 units of the Company (each a “Unit” and collectively, the “Units”) at a price of C$0.05 per Unit for gross proceeds of C$285,045.00. Each Unit consists of one common share of the Company (each, a “Common Share”) and one common share purchase warrant (each a “Warrant”). Each Warrant will entitle the holder to acquire one additional Common Share of the Company at an exercise price...

Continue reading

Titanium Transportation Suspends Quarterly Dividend to Fortify Balance Sheet Amid Market Uncertainty

BOLTON, Ontario, Feb. 07, 2025 (GLOBE NEWSWIRE) — Titanium Transportation Group Inc. (“Titanium” or the “Company”) (TSX:TTNM, OTCQX:TTNMF), a leading provider of transportation and logistics services throughout North America, today announced that its Board of Directors (the “Board”) has elected to suspend its dividend as the Company continues to execute a disciplined financial strategy amid ongoing market challenges. “Given the current softness in our core markets and growing uncertainty surrounding potential tariff changes, we are adopting a proactive and disciplined approach to capital allocation,” commented Ted Daniel, Chief Executive Officer of Titanium. “While we are seeing some early signs of economic stabilization, the overall outlook remains uncertain due to the ongoing macroeconomic and geopolitical...

Continue reading

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and recommendations by the trial’s independent Data Safety Monitoring Board (DSMB), the Company has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF). Patients currently enrolled in BEACON-IPF will remain in the trial. Enrollment and dosing have been paused while data is reviewed to understand the DSMB’s rationale for their recommendation. Blinding of the study will be maintained to preserve trial...

Continue reading

Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period

This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this press release and in the offer document published on the transaction website (www.raredisease-offer.com). Shareholders in the United States should also refer to the section titled “Special notice to shareholders in the United States” at the end of this press release. Leiden,...

Continue reading

Retail Opportunity Investments Corp. Stockholders Approve Acquisition by Blackstone Real Estate

SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ: ROIC) (“ROIC” or the “Company”) today announced that, at the concluded special meeting of stockholders held earlier today, its stockholders approved the all-cash acquisition of the Company by Blackstone Real Estate Partners X (“Blackstone”). The Company will provide final vote results for the special meeting, as certified by the independent Inspector of Election, on a Current Report on Form 8-K to be filed with the U.S. Securities and Exchange Commission (the “SEC”). As previously announced, the Company and affiliates of Blackstone have entered into a definitive merger agreement, pursuant to which such affiliates of Blackstone have agreed to acquire the outstanding shares of common stock of the Company for $17.50 per share. The proposed acquisition...

Continue reading

Nokia Corporation: Repurchase of own shares on 07.02.2025

Nokia CorporationStock Exchange Release7 February 2025 at 22:30 EET Nokia Corporation: Repurchase of own shares on 07.02.2025 Espoo, Finland – On 7 February 2025 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 1,400,000 4.64CEUX – –BATE – –AQEU – –TQEX – –Total 1,400,000 4.64* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

Avis Budget Group to Announce Fourth Quarter 2024 Results on February 11th

Conference Call to Discuss Results Scheduled for February 12th, 2025 PARSIPPANY, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its fourth quarter 2024 results after the market close on Tuesday, February 11th, 2025, and to host a conference call for institutional investors to discuss these results on Wednesday, February 12th, 2025 at 8:30 a.m. Eastern time. Investors may access the call at ir.avisbudgetgroup.com, or by dialing (877)-407-2991. Investors are encouraged to dial in approximately 10 minutes prior to the call. A web replay will be available at ir.avisbudgetgroup.com following the call. A telephone replay will be available from 11:00 a.m. Eastern time on February 12th, 2025, until 10:00 p.m. on February 26th at (877)-660-6853 using conference code 13751081. About...

Continue reading

Western Star Resources Inc. Announces Closing of Debt Settlement Agreements

VANCOUVER, British Columbia, Feb. 07, 2025 (GLOBE NEWSWIRE) — Western Star Resources Inc. (WSR: CSE) is pleased to announce that it has closed the previously announced Shares for Debt Settlement transactions (see press release dated February 3, 2025) to settle an aggregate of CDN$209,400 (the “Debt”) owed to certain officers and directors of the Corporation (the “Creditors”) by issuing an aggregate of 1,745,000 common shares (the “Shares”) of the Corporation at a deemed price of $0.12 per share. The Shares are subject to a hold period of four months and one day. Accordingly, the portion of the debt settlement with the insiders constitutes a related-party transaction within the meaning of Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). The issuance of the shares to the insiders is...

Continue reading

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

BOCA RATON, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) — Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it has secured a $2 million revolving loan agreement and subsequently appointed three new members to its Board of Directors. As a condition for the loan, Entero replaced three of five members of its Board of Directors with three new directors designated by the lender. These appointments follow the resignations of James Sapirstein, Alastair Riddell and Timothy Ramdeen from the Board. Richard Paolone, a Toronto-based securities lawyer with leadership experience at public and private companies, joins the Board alongside Eric Corbett, a managing director...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.